Pular para o conteúdo

Brepocitinib tied to better dermatomyositis skin and itch

29 de agosto de 2026 · 13 min

Notas do episódio

Editor's Pick: Skin-Specific Outcomes of Brepocitinib in Patients With Dermatomyositis: Secondary Analysis of a Phase 3 Randomized Clinical Trial (JAMA Dermatology, 2026)

Welcome to This Week in Dermatology. This week we're covering 10 notable papers spanning systemic drug safety and the cardiometabolic interface, new targeted therapy data in inflammatory and neutrophilic skin disease, risk stratification in skin cancer, and a pair of papers that together make a strong case for looking below the neck in acne. Let's dive in.

This week's papers:

  1. Cardiometabolic Associations of Dermatological Treatments. Part I: Systemic Therapies.. Journal of the American Academy of Dermatology 2026
  2. Cardiometabolic Associations of Dermatological Treatments. Part II: Targeted and Biologic Therapies.. Journal of the American Academy of Dermatology 2026
  3. Skin-Specific Outcomes of Brepocitinib in Patients With Dermatomyositis: Secondary Analysis of a Phase 3 Randomized Clinical Trial.. JAMA Dermatology 2026
  4. A Delphi Consensus on Tildrakizumab Dosing and Titration in Moderate-to-Severe Plaque Psoriasis.. Acta Dermato-Venereologica 2026
  5. Validation of the integrated 40-gene expression profile (i40-GEP) which provides prognostic and adjuvant radiation benefit for high-risk cutaneous squamous cell carcinoma.. Journal of the American Academy of Dermatology 2026
  6. Comorbidity-Guided Management of Pyoderma Gangrenosum: A Clinical Guide to Emerging Therapeutic Targets.. Journal of the American Academy of Dermatology 2026
  7. Global Disparities in Access to Dermatological Care.. JAMA Dermatology 2026
  8. Laser and Energy-Based Device Use in Skin of Color: A Clinical Review of Safety, Efficacy, and Best Practices.. Journal of the American Academy of Dermatology 2026
  9. Truncal Acne Is Independently Associated with Stigmatization, Poorer Treatment Adherence and Greater Healthcare Utilization: A 20-country Survey.. Acta Dermato-Venereologica 2026
  10. Effectiveness, safety and tolerability of Ozenoxacin 2% lotion vs Clindamycin 1% lotion in mild to moderate truncal acne: An open label randomized controlled clinical trial.. Clinical and Experimental Dermatology 2026

Listen at AudioScholar

Todos os episódios de AudioScholar Dermatology Weekly (India)

Configurações

Exibição

Idioma

Define quais estações você vê primeiro na página inicial.

Histórico

As rádios e episódios ouvidos recentemente e suas últimas buscas ficam só neste navegador.

Avisos

Um aviso rápido quando um podcast que você segue tem um episódio novo. Desative podcasts individuais pelo sino na página deles.

Conta

Salve favoritos – no app e no site.

Atalhos de teclado

/
Abrir busca
Espaço
Reproduzir ou pausar
← →
No player: voltar 15 s, avançar 30 s (episódios) · na fileira: próximo bloco
↑ ↓
Na fileira: alvo dentro do bloco
Home / End
Na fileira: primeiro ou último bloco
Esc
Fechar janela ou menu
?
Esta visão geral
Tocando agora

Ir para a estação

A seguir

    Adicione episódios com “A seguir” – eles tocam depois do episódio atual.